Failure To Thrive in Child. Other lack of expected normal physiological development
Conditions
Interventions
Intervention 1: Intervention group: The intervention group received the following routine treatment: All the studied children received routine treatment in the form of daily zinc 0.3 mg/kg body weight
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 14 Years
Inclusion criteria
Inclusion criteria: 2-14-year-old patients with failure to thrive whose Z-SCORE weight is below -2.
Exclusion criteria
Exclusion criteria: type 3 failure to thrive Type 2 growth disorder that hormonal problems have not been ruled out by an endocrinologist. cardiovascular diseases pulmonary diseases malabsorption Pancreatic exocrine insufficiency steatorrhea renal diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight gain. Timepoint: At the beginning and 2 months after. Method of measurement: Weight is measured by a Seca scale (Germany) [this scale is calibrated every day], then the patients will be treated for 2 months and re-examined with the same scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Height raise. Timepoint: at the beginning and 2 months after. Method of measurement: Height is measured by a tape measure from Seka (Germany), standing without shoes and attached to the wall at the beginning and 2 months after treatment.;BMI raise. Timepoint: at the beginning and 2 months after. Method of measurement: BMI is calculated by dividing weight in kilograms by height in square meters.;Z score raise. Timepoint: at the beginning and 2 months after. Method of measurement: By putting weight, height, and BMI in the Medscape calculator software, the Z SCORE number is reported. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShohreh Maleknejad
Rasht University of Medical Sciences
Outcome results
None listed